Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,512.40
(
-0.03%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
98.22
(
1.48%
)
Bitcoin
71,296.00
(
0.56%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 89398

Tuesday, 07/10/2012 8:07:42 AM

Tuesday, July 10, 2012 8:07:42 AM

Post# of 257273
FDA places clinical hold on Ipsen’s Factor IX program due to detectable antibodies against CHO proteins used in manufacturing:

http://finance.yahoo.com/news/ipsen-partner-inspiration-biopharmaceuticals-announces-050000739.html

Factor IX the lead program among several hemophilia-related projects pursuant to a 2010 collaboration between Ipsen and Inspiration Biopharma (#msg-45759144).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today